Puppo P, Perachino M, Ricciotti G, Bozzo W
Department of Urology, S. Corona Hospital, Pietra Ligure (SV), Italy.
Arch Esp Urol. 1994 Nov;47(9):867-72.
The first problem to be solved in the evaluation of BPH patients is surely the differential diagnosis with prostate carcinoma. We evaluated the impact of a combined approach for prostate cancer detection using DRE, PSA, TRUS and ultrasound-guided biopsy, determining the sensitivity and specificity of different tools, in order to obtain a diagnostic algorithm to be used for pretreatment differential diagnosis between prostate cancer and BPH.
在评估良性前列腺增生（BPH）患者时，首先要解决的问题无疑是与前列腺癌进行鉴别诊断。我们评估了联合应用直肠指检（DRE）、前列腺特异性抗原（PSA）、经直肠超声检查（TRUS）和超声引导下活检进行前列腺癌检测的影响，确定了不同检查手段的敏感性和特异性，以获得一种可用于前列腺癌与BPH治疗前鉴别诊断的诊断算法。
